SILDOSAF D 8/0.5 CAPSULE

Product Description

SILDOSAF D 8/0.5 CAPSULE is a potent combination pharmaceutical designed for the effective management of Benign Prostatic Hyperplasia (BPH). Each capsule contains Silodosin 8 mg, an alpha-1 adrenergic receptor blocker, and Dutasteride 0.5 mg, a 5-alpha-reductase inhibitor, working synergistically to relieve urinary symptoms and reduce prostate size.

This dual-action formulation is highly sought after by medical distributors, retail pharmacies, and bulk buyers due to its proven efficacy in improving urinary flow and decreasing the risk of BPH progression. Manufactured under stringent quality standards, SILDOSAF D ensures consistent therapeutic outcomes and safety.

Key Benefits:

• Combats lower urinary tract symptoms (LUTS) associated with BPH

• Silodosin relaxes prostate and bladder muscles for better urine flow

• Dutasteride reduces prostate enlargement by inhibiting DHT production

• Enhances patient compliance with once-daily oral dosage

• GMP-certified for quality, safety, and purity

Usage:

• Prescribed for men suffering from benign prostatic hyperplasia

• Effective in reducing urinary retention and improving quality of life

• Ideal for long-term management to prevent BPH complications

Why Choose SILDOSAF D 8/0.5 CAPSULE?

• Trusted combination therapy for enhanced BPH symptom relief

• Bulk availability ideal for distributors, hospitals, and pharmacies

• Competitive pricing with reliable supply chain support